205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
18.22%
Some net income increase while AVGO is negative at -9.78%. John Neff would see a short-term edge over the struggling competitor.
1.03%
Some D&A expansion while AVGO is negative at -0.37%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy SBC while AVGO is 38.36%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
70.93%
Well above AVGO's 18.76% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-100.00%
Both yoy AR lines negative, with AVGO at -9.46%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-153.57%
Negative yoy inventory while AVGO is 26.35%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
100.00%
A yoy AP increase while AVGO is negative at -354.36%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
60.21%
Growth well above AVGO's 68.61%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
686.67%
Some yoy increase while AVGO is negative at -33.99%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
62.09%
Operating cash flow growth above 1.5x AVGO's 7.23%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
2.79%
Some CapEx rise while AVGO is negative at -44.00%. John Neff would see competitor possibly building capacity while we hold back expansions.
100.00%
Acquisition growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-74.50%
Negative yoy purchasing while AVGO stands at 45.71%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
51.73%
Below 50% of AVGO's 333.33%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-200.00%
Both yoy lines negative, with AVGO at -176.92%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-188.64%
We reduce yoy invests while AVGO stands at 23.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
142.86%
Issuance growth of 142.86% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
13.42%
We have some buyback growth while AVGO is negative at -107.07%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.